Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus non-structural protein 5 (NSP5) is a critical 22-kDa phosphoprotein encoded by the eleventh genomic segment of the Rotavirus genome (UniProt: P0C0M5). It serves as a primary scaffold for the formation of viroplasms, which are specialized cytoplasmic inclusions where viral RNA replication and early particle assembly occur (PubMed: 11832469). NSP5 undergoes a complex process of hyperphosphorylation that is essential for its function, a process triggered and regulated by its interaction with the viral protein NSP2 (PubMed: 15140983). As Rotavirus remains a leading cause of severe, dehydrating diarrhea and gastroenteritis in infants worldwide, NSP5 represents a vital target for the development of novel antiviral therapies (NIH: Rotavirus). Current research into targeting NSP5 involves the use of small molecule inhibitors and RNA interference to disrupt viroplasm assembly or inhibit the phosphorylation cascade necessary for viral propagation (PubMed: 22496221).
Disruption of viroplasm assembly and inhibition of viral RNA replication by interfering with NSP5 phosphorylation or its interaction with NSP2 (PubMed: 22496221).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus non-structural protein 5 (NSP5) (NSP5).